NeurAxis Trading Up 4.4%NRXS traded up $0.29 during trading on Tuesday, hitting $6.88. State Street Corp acquired a new stake in NeurAxis in the 4th quarter worth $139,000. Finally, Rosalind Advisors Inc. bought a new position in shares of NeurAxis during the 4th quarter worth about $1,299,000. NeurAxis Company ProfileNeurAxis (NASDAQ: NRXS) is a clinical-stage biotechnology company focused on the discovery and development of therapeutic candidates for diseases of the central nervous system. Featured StoriesReceive News & Ratings for NeurAxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NeurAxis and related companies with MarketBeat.com's FREE daily email newsletter.